Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.668 USD | -0.30% | -14.77% | -26.79% |
Mar. 13 | Transcript : Gossamer Bio, Inc. Presents at Barclays 26th Annual Global Healthcare Conference 2024, Mar-13-2024 07:30 AM | |
Mar. 12 | Gossamer Bio Announces Board of Directors Appointments | CI |
Evolution of the average Target Price on Gossamer Bio, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Gossamer Bio, Inc.
Goldman Sachs | |
HC Wainwright | |
Wedbush | |
UBS | |
Barclays | |
Raymond James | |
Guggenheim | |
SMBC Nikko | |
SVB Securities LLC | |
JPMorgan Chase | |
Cantor Fitzgerald | |
Piper Sandler | |
SVB Leerink |
EPS Revisions
- Stock Market
- Equities
- GOSS Stock
- Consensus Gossamer Bio, Inc.